---
schema_version: "secwatch.filing_event.v1"
accession: "0001528287-25-000021"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2025-08-12T23:59:59+00:00"
generated_at: "2026-05-17T14:28:43.283331+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NeuroPace posts Q2 revenue $23.5M (+22% YoY); raises FY2025 revenue and margin guidance

## Summary
- Revenue grew 22% YoY to $23.5M; RNS System revenue up 16% in Q2.
- Full-year 2025 revenue guidance raised to $94-98M (previous $93-97M).
- Gross margin 77.1% in Q2; FY margin guidance increased to 75-76%.
- Net loss $8.7M vs $7.5M; free cash flow improved to ($2.3M).
- NAUTILUS IGE study missed primary endpoint but showed 79% GTC seizure reduction at 12 months.

## SEC filing metadata
- accession: 0001528287-25-000021
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2025-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000021/0001528287-25-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000021/npce-20250812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001528287-25-000021
- JSON: https://secwatch.observer/filing/0001528287-25-000021.json
- Plain text: https://secwatch.observer/filing/0001528287-25-000021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.